Wunderlich’s syndrome associated with anticoa­ gulant treatment, heart failure, and post‐radiation vasculopathy

Journal Title: Journal of Rare Cardiovascular Diseases - Year 2019, Vol 4, Issue 2

Abstract

Background: Wunderlich’s syndrome (WS) is an extremely rare condition, characterised by spontaneous haemorrhage into the subcapsular, perirenal, and retroperitoneal spaces. The most common cause is renal angiomyolipoma. Classic symptoms, such as acute flank pain, flank mass, and hypovolemic shock, known as Lenk’s triad, have limited sensitivity and specificity for detecting WS. High mortality may be related to the difficulties in diagnosis, poor disease recognition, and non‐specific symptoms and signs. Computed tomography (CT) is the method of choice for the diagnosis of WS. Depending on the severity of symptoms, a conservative or invasive approach is reasonable. Methods and results: We report the case of a 58‐year‐old male with multivalvular heart defect, atrial fibrillation, and exacerbation of chronic heart failure complicated with nontraumatic bleeding into the retroperitoneal space. CT revealed a massive (14x11x26 cm) retroperitoneal and perirenal haematoma. The patient was successfully treated with transfusion of red blood cells, fresh frozen plasma, and intravenous fluids. Simultaneously, heart failure treatment was initiated. In view of the chronic and idiopathic character of the haematoma and successful conservative treatment, there was no indication for surgery. Discussion: Several factors might have contributed to the bleeding. First, the patient was receiving anticoagulant treatment to reduce the risk of arterial thromboembolism in atrial fibrillation. Another possible cause is post‐radiation vasculopathy, an adverse effect of previous radiation therapy for malignant granuloma. The third factor which could have contributed to bleeding was the exacerbation of chronic heart failure and pulmonary hypertension. JRCD 2019; 4 (2): 51-55.

Authors and Affiliations

Adam Pytlewski, Mateusz Siwek, Leszek Drabik, Miłosz Delikat, Dawid Śmietana, Ewa Sobieraj, Paweł Iwaszczuk, Wojciech Płazak

Keywords

Related Articles

Report from the European Society of Cardiology Congress 2015 in London

At least for us, the ESC Congress 2015 in London was different from the previous ones as we did not organize Satellite Symposium on rare cardiovascular diseases. It is not that we did not want to, on the contrary we trie...

Journal of Rare Cardiovascular Diseases: All that glitters is not gold. Randomized Controlled Trails versus real‑life patients: Challenges of a maturing Journal

Dear Readers,Is time friend or foe? No one has the right answer. With this issue, we are celebrating an important landmark in the Journal’s history. On this occasion, we have looked back at our first two years with a pin...

3rd Symposium on Rare Cardiovascular Diseases – ESC Amsterdam 2013: Chairperson’s Perspective

The 3rd Satellite Symposiumon Rare Cardiovascular Diseases, which was organized by the Krakow Center for Rare Cardiovascular Diseases, was officially included in the Program of the 2013 ESC Congress and was held in the E...

Heart in Fabry Disease

Fabry disease is one of the lysosomal storage disorders, that results from progressive multiorgan accumulation of glycoproteins. It is caused by mutations of the GLA gene, which encodes alpha-galactosidase A. The  incide...

Exercise ECG unmasked Brugada sign: manifestation of the risk of sports‑associated sudden cardiac arrest (RCD code: V‑1A.1)

Sports‑associated sudden cardiac arrest (SCA) constitutes an important problem. Causes of SCA during sport activities include Brugada syndrome (BrS) among others. We describe a 29‑year‑old male, without a history of card...

Download PDF file
  • EP ID EP630624
  • DOI 10.2041/jrcd.vol4no2.370
  • Views 102
  • Downloads 0

How To Cite

Adam Pytlewski, Mateusz Siwek, Leszek Drabik, Miłosz Delikat, Dawid Śmietana, Ewa Sobieraj, Paweł Iwaszczuk, Wojciech Płazak (2019). Wunderlich’s syndrome associated with anticoa­ gulant treatment, heart failure, and post‐radiation vasculopathy. Journal of Rare Cardiovascular Diseases, 4(2), 51-55. https://europub.co.uk/articles/-A-630624